logo

Iterum Therapeutics Plc (ITRM)



Trade ITRM now with
  Date
  Headline
1/25/2021 7:14:23 AM Iterum Says FDA Accepted For Review NDA For Sulopenem Etzadroxil/probenecid
12/23/2020 7:09:55 AM Iterum Therapeutics' Michael Dunne Resigns As Chief Scientific Officer
12/7/2020 8:20:28 AM Iterum Announces Filing Of A U.S. National Phase Patent Application
9/30/2020 7:11:27 AM Iterum Therapeutics Announces Positive Pre-NDA Meeting With FDA For Sulopenem For Uncomplicated Urinary Tract Infections
9/2/2020 7:07:57 AM Iterum Therapeutics Revises Results Of Its Pending Rights Offering